EC approves Pelmeg: Mundipharma’s answer to chemotherapy-induced neutropenia
Mundipharma, a German pharmaceutical company, has achieved a significant milestone with the European Commission (EC)'s approval of Pelmeg, its pegylated biosimilar to Amgen’s Neulasta (pegfilgrastim). ... Read More
Spark Therapeutics’ Luxturna gains EU approval as first gene therapy for inherited retinal disease
In a significant breakthrough for treating inherited vision loss, Pennsylvania-based Spark Therapeutics has received European Commission (EC) approval for its pioneering gene therapy, Luxturna (voretigene ... Read More
Armas Pharmaceuticals launches first injectable in US with Vidaza generic
Armas Pharmaceuticals has entered the US injectable drug market with its launch of Azacitidine for Injection 100 MG, a generic version of Vidaza, targeting myelodysplastic ... Read More
Novartis’ Promacta approved by FDA for first-line treatment of severe aplastic anemia
The U.S. Food and Drug Administration (FDA) has granted an expanded indication for Novartis’ Promacta (eltrombopag), approving it for use in the first-line treatment of ... Read More
Brooklyn Immuno Therapeutics acquires IRX Therapeutics’ assets for cytokine-based cancer therapy
Brooklyn Immuno Therapeutics, a New York-based clinical-stage biopharmaceutical company specializing in cytokine-based cancer therapies, has announced the acquisition of IRX Therapeutics' assets. The terms of ... Read More
Seattle Genetics’ Adcetris receives FDA approval for peripheral T-cell lymphoma
Seattle Genetics' Adcetris, in combination with CHP chemotherapy, gains FDA approval for treating certain types of peripheral T-cell lymphoma. Seattle Genetics has announced that the ... Read More
Cosmo Technologies secures FDA approval for Aemcolo to treat travelers’ diarrhea
Cosmo Technologies has achieved a significant milestone with the recent approval from the U.S. Food and Drug Administration (FDA) for its antibacterial drug, Aemcolo (rifamycin). ... Read More
4D Molecular Therapeutics’ 4D-110 receives FDA orphan drug designation for choroideremia
4D Molecular Therapeutics (4DMT), a prominent California-based gene therapy firm, has achieved a significant milestone with the US Food and Drug Administration (FDA) granting orphan ... Read More
Surgical menopause increases risk of sleep disorders than natural menopause
According to latest study, it is revealed that surgical menopause leads to increase in risk of insomnia in women compared to natural menopause. Surgical menopause ... Read More
Know about maize oil medicinal uses, chemical constituents and synonyms
Maize oil or Corn oil is a fatty oil obtained from the plant Zea mays. Corn can be eaten after frying in the coal and ... Read More